Use of Quinvaxem vaccine will resume next month after a five-month suspension following the death of nine children who received the vaccine this year.

The vaccine, which prevents five common, potentially fatal childhood diseases, including diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenza type B, has since been tested for by the Ministry of Health and other domestic and international organisations, said director of the ministry’s Preventive Medicine Department Nguyen Van Binh.

Findings failed to provide evidence that the deaths were related to the quality of the vaccine, experts said.
The ministry imported 1.5 million doses of the vaccine made by the Republic of Korea’s Berna Biotec Company.

A total of 380,000 children will receive the vaccine each month, according to the department. The vaccine has been used in the country since 2010.-VNA